New Data Presented on the Safety and Efficacy of Investigational AGN-190584 as a Potential Novel Treatment for Presbyopia, a Common and Progressive Eye Condition
Allergan, an ABBVie company, today announced new data, including the full results from the Phase 3 GEMINI 1 clinical study,...
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index
S&P Dow Jones Indices announces the following changes to the S&PTSX Composite Index: Aurinia Pharmaceuticals Inc has announced that the...
DALVANCE® Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
ABBVie today announced that the U.S. Food and Drug Administration approved DALVANCE® for the treatment of acute bacterial skin and...
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Dose deliveries for new order expected to occur from October 2021 through April 2022 Pfizer Inc. and BioNTech SE today...
Jamieson Wellness Inc. Announces Date of Second Quarter 2021 Financial Results and Conference Call
Jamieson Wellness Inc. announced today that the Company will release its second quarter 2021 financial results after the market close...
Abbott Reports Second-Quarter 2021 Results
Abbott today announced financial results for the second quarter ended June 30, 2021 . Second-quarter sales of $10.2 billion increased...
Salix Announces 2021 Gastrointestinal Health Scholars Program Winners
Bausch Health Companies Inc. and its gastroenterology business, Salix Pharmaceuticals, one of the largest specialty pharmaceutical companies in the world...